Peter Imrey, PhD

Appointed
2001

Education & Fellowships

Medical Education - University of North Carolina at Chapel Hill
Biostatistics
Chapel Hill, NC
1972

Undergraduate - Columbia College
Mathematics & Statistics
New York, NY
1966

Additional Training

• A.B. (Mathematics and Statistics), Columbia College, N.Y.
• PhD (Biostatistics and Epidemiology), University of North Carolina at Chapel Hill
• Participated in numerous short courses on advanced statistical and epidemiologic methods at Johns Hopkins University, International Biometric Society and American Statistical Association

Professional Highlights

• International Biometric Society: Governing Council, 1993-1995; President, Eastern North American Region, 2005
• American Statistical Association: Council of Sections, 1991; Chair, Section on Teaching Statistics in the Health Sciences, 1992; Chair, Biometric Section, 1997
• American Public Health Association: Governing Council, 1992-1994; Statistics Section Recognition Award, 1996; Chair, Statistics Section, 2002
• Associate Editor, "Encyclopedia of Biostatistics," 2nd Edition
• National Research Council, National Academy of Sciences panels on polygraph testing and biometric identification, and numerous additional scientific panels and review groups

Specialty Interests

biostatistics, categorical data analysis, dental and oral research, diet and cancer, epidemiology, meningococcal meningitis, sample survey methods

Awards & Honors

• President's Invited Speaker, 56th Biannual Session of the International Statistical Institute, 2007
• President, Eastern North American Region, International Biometric Society, 2005
• American Public Health Association Recognition Award
• Fellow, American College of Epidemiology
• Robert Bohrer Memorial Lecturer, University of Illinois at Urbana-Champaign
• Delta Omega
• Sigma Xi

Memberships

• International Biometric Society
• American Statistical Association
• American College of Epidemiology
• Society for Epidemiological Research
• American Public Health Association

See publications for Peter Imrey, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/3/2024, Dr. Imrey has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Fiduciary Role. Dr. Imrey serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

• Task Force on Design & Analysis, Inc.
• Foundation for Design and Analysis of Dental and Oral Research

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.